Subtype-specific Breast Cancer Risk in Highly Indigenous Latin American Women

The Genomics and Health Disparities Lecture Series, co-sponsored by NIH and the Food and Drug Administration Office of Minority Health (FDA OMH), will address genetic and non-genetic factors that increase the risk for and affects the prognosis of breast cancer in Hispanics/Latinas. June 25, 3:00 pm ET.

Tuesday, June 25, 2020, 3:00 - 4:00 p.m.

Laura Fejerman, Ph.D.
Assistant Professor
Department of Medicine
University of California, San Francisco